| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2026―Feb―11 |
Patient engagement with home blood pressure monitoring - cannot have been properly assessed during the pandemic |
Julian Eek Mariampillai, Camilla Lund Søraas, Sverre E. Kjeldsen |
| 2 |
[GO] |
2025―Apr―17 |
Higher blood pressure variability during hospitalization is associated with lower cerebral white matter integrity in COVID-19 patients |
Theresa J van Lith, Esther Janssen, Jan-Willem van Dalen, Hao Li, Mats Koeneman, Wouter M Sluis, et al. (+8) Naomi T Wijers, Marieke JH Wermer, Menno V Huisman, H. Bart van der Worp, Frederick JA Meijer, Anil M Tuladhar, Sebastian JH Bredie, Frank-Erik de Leeuw |
| 3 |
[GO] |
2023―Jan―25 |
Ambulatory blood pressure monitoring in treated patients with hypertension in the COVID-19 pandemic - The study of European society of hypertension (ESH ABPM COVID-19 study) |
Wiktoria Wojciechowska, Marek Rajzer, Thomas Weber, Aleksander Prejbisz, Piotr Dobrowolski, Aleksandra Ostrowska, et al. (+4) Grzegorz Bilo, Giuseppe Mancia, Reinhold Kreutz, Andrzej Januszewicz |
| 4 |
[GO] |
2022―May―12 |
Soluble ACE2 and angiotensin II levels are modulated in hypertensive COVID-19 patients treated with different antihypertension drugs |
Mohamed A. Elrayess, Hadeel T. Zedan, Rand A. Alattar, Hatem Abusriwil, Mahmoud Khatib A. A. Al-Ruweidi, Shamma Almuraikhy, et al. (+12) Jabeed Parengal, Bassem Alhariri, Hadi M. Yassine, Ali A. Hssain, Arun Nair, Musaed Al Samawi, Alaaeldin Abdelmajid, Jassim Al Suwaidi, Mohamed Omar Saad, Muna Al-Maslamani, Ali S. Omrani, Huseyin C. Yalcin |
| 5 |
[GO] |
2022―Apr―23 |
Covid-19 associated reduction in hypertension-related diagnostic and therapeutic procedures in Excellence Centers of the European Society of Hypertension |
Thomas Weber, Jaques Amar, Tine de Backer, Thilo Burkard, Marcus van der Giet, Philippe Gosse, et al. (+9) Andrzej Januszewicz, Thomas Kahan, Giuseppe Mancia, Christopher C. Mayer, Maria Lorenza Muiesan, George S. Stergiou, Konstantinos Tsioufis, Bernard Vaisse, Reinhold Kreutz |
| 6 |
[GO] |
2022―Apr―15 |
Hypertension management during the COVID-19 pandemic: what can we learn for the future? |
Michel Burnier, Sverre E. Kjeldsen, Krzysztof Narkiewicz, Brent Egan, Reinhold Kreutz |
| 7 |
[GO] |
2020―Dec―22 |
Potential protective effects of antihypertensive treatments during the Covid-19 pandemic: from inhibitors of the renin-angiotensin system to beta-adrenergic receptor blockers |
Sverre E. Kjeldsen, Krzysztof Narkiewicz, Michel Burnier, Suzanne Oparil |
|
